Thursday, January 26, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

NHLBI Updates Research Topics of Special Interest

by Global Biodefense Staff
July 14, 2016
NHLBI Research Topics of Special Interest

NHLBI Research Topics of Special InterestThe National Heart, Lung, and Blood Institute (NHLBI) this week provided an update to its research topics of special interest for funding via Small Business Technology Transfer (STTR) and Small Business Innovation Research (SBIR) mechanisms.

Highlighted topics include:

  • Animal and cellular models for transfusion of blood products or cell-based therapies
  • Improved methods to assess, monitor, or predict cardiovascular toxicity of therapeutic agents
  • Imaging, reagents, assays, microfluidics, bioinformatics and nanotechnology for investigations of blood diseases, transfusion and cellular therapies
  • Diagnostics: devices, biomarkers, imaging, and assays for non-malignant blood disorders
  • Drugs, blood product, cellular therapies, and gene therapy for non-malignant blood disorders
  • E-medicine Apps for patients and medical professionals to improve the management of and reduce the impact of non-malignant blood diseases
  • Development of targeted molecular imaging reagents/techniques and nanotechnology-based drug delivery systems
  • Development of reagents and methods to identify and isolate stem/progenitor cells, and direct differentiation to specific functional organ units
  • Development and validation of techniques (or algorithms) to study the microbiome in situ
  • Characterization and in vivo or in vitro applications of miRNA panels that directly or indirectly promote lung repair or regeneration
  • Development of high throughput methods to apply microfluidics technology in discovery of molecular profiles (DNAs, RNAs, proteins, or metabolites) in a large number of sputum or exhaled breath condensate samples collected from lung disease patients
  • Applicable high-definition, biocompatible mesh technologies made from nanoscale materials

Investigators interested in developing applications for these topics are encouraged to discuss their ideas with the NHLBI program official indicated for each topic. Although funds are not specifically set aside for awards on these topics, applications submitted are eligible for special funding consideration.

Further details are available via Notice Number: NOT-HL-16-332 and at the NHLBI Omnibus Grant Solicitations for Investigator-Initiated Applications website.

Tags: Animal ModelsBioinformaticsBiomarkersNIHRequest for Proposals

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
The device appears smaller than a playing card, transparent, with visible channels branching off.
Medical Countermeasures

How Organ-on-a-chip Models Could Grease the Drug Development Pipeline

January 10, 2023
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC